Pharmaceutical Investing Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan
Pharmaceutical Investing Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
Pharmaceutical Investing VBL Therapeutics Presents Late Breaking Research Demonstrating Immune-cell Mediated Killing of Cancer Cells by a Novel Bi-specific Antibody at AACR
Pharmaceutical Investing Moleculin Announces Patients Treated in FDA Approved Phase I/II Annamycin Clinical Trial
Pharmaceutical Investing Moleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials
Noble Mineral highlights Successful Exploration Results announced by Canada Nickel, including Highest Grade to Date at Mann West
CHARBONE Hydrogen and ABB Sign Agreement to Advance North American Green Hydrogen Production Facilities
CHARBONE Hydrogene et ABB signent une entente pour accelerer les usines de production d'hydrogene vert en Amerique du Nord
